Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
APC
Anadarko Petroleum
APC
|
+$177M |
| 2 |
ConocoPhillips
COP
|
+$174M |
| 3 |
PepsiCo
PEP
|
+$165M |
| 4 |
AT&T
T
|
+$154M |
| 5 |
Fidelity National Information Services
FIS
|
+$147M |
Top Sells
| 1 |
NextEra Energy, Inc.
NEE
|
+$263M |
| 2 |
PPL Corp
PPL
|
+$257M |
| 3 |
Occidental Petroleum
OXY
|
+$226M |
| 4 |
Lowe's Companies
LOW
|
+$193M |
| 5 |
American Electric Power
AEP
|
+$183M |
Sector Composition
| 1 | Healthcare | 12.99% |
| 2 | Energy | 10.03% |
| 3 | Technology | 9.74% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBA
1626
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.92M | ﹤0.01% |
91,695
-31,617
| -26% | -$662K |
|
|
SCMP
1627
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.92M | ﹤0.01% |
175,317
+101,319
| +137% | +$1.11M |
|
1628
Travel + Leisure Co
TNL
$4.02B
| $1.91M | ﹤0.01% |
55,322
-612,500
| -92% | -$21.1M |
|
|
INWK
1629
DELISTED
InnerWorkings, Inc.
INWK
| $1.9M | ﹤0.01% |
+239,292
| New | +$1.9M |
|
1630
DNOW Inc
DNOW
$1.6B
| $1.9M | ﹤0.01% |
107,274
+91,111
| +564% | +$1.61M |
|
1631
Otter Tail
OTTR
$3.48B
| $1.9M | ﹤0.01% |
64,089
+21,086
| +49% | +$624K |
|
1632
Esperion Therapeutics
ESPR
$573M
| $1.89M | ﹤0.01% |
111,577
+14,968
| +15% | +$253K |
|
1633
Zurn Elkay Water Solutions
ZWS
$7.82B
| $1.89M | ﹤0.01% |
193,649
-1,218,859
| -86% | -$11.9M |
|
|
TOWR
1634
DELISTED
Tower International, Inc.
TOWR
| $1.89M | ﹤0.01% |
69,305
+18,226
| +36% | +$496K |
|
1635
Peapack-Gladstone Financial
PGC
$517M
| $1.88M | ﹤0.01% |
111,354
+88,710
| +392% | +$1.5M |
|
|
ONC
1636
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.7B
| $1.88M | ﹤0.01% |
+64,087
| New | +$1.88M |
|
1637
Modine Manufacturing
MOD
$7.86B
| $1.88M | ﹤0.01% |
170,490
-1,126
| -0.7% | -$12.4K |
|
|
ARIA
1638
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.87M | ﹤0.01% |
293,232
+15,598
| +6% | +$99.7K |
|
|
VVC
1639
DELISTED
Vectren Corporation
VVC
| $1.87M | ﹤0.01% |
37,011
-703
| -2% | -$35.5K |
|
|
ORBK
1640
DELISTED
Orbotech Ltd
ORBK
| $1.87M | ﹤0.01% |
78,544
-218,182
| -74% | -$5.19M |
|
|
CNH
1641
CNH Industrial
CNH
$13.7B
| $1.87M | ﹤0.01% |
317,408
+303,100
| +2,118% | +$1.78M |
|
1642
Genworth Financial
GNW
$3.61B
| $1.86M | ﹤0.01% |
682,264
-1,432,263
| -68% | -$3.91M |
|
1643
Qualys
QLYS
$4.82B
| $1.86M | ﹤0.01% |
73,604
-42,161
| -36% | -$1.07M |
|
1644
National Healthcare
NHC
$1.78B
| $1.86M | ﹤0.01% |
29,867
+26,259
| +728% | +$1.64M |
|
1645
Oaktree Specialty Lending
OCSL
$1.21B
| $1.86M | ﹤0.01% |
123,360
+119,615
| +3,194% | +$1.8M |
|
|
GMLP
1646
DELISTED
Golar LNG Partners LP
GMLP
| $1.86M | ﹤0.01% |
126,276
-11,906
| -9% | -$175K |
|
1647
Teekay
TK
$722M
| $1.85M | ﹤0.01% |
213,762
+52,091
| +32% | +$451K |
|
|
INSY
1648
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.85M | ﹤0.01% |
115,552
+5,557
| +5% | +$88.9K |
|
|
RGC
1649
DELISTED
Regal Entertainment Group
RGC
| $1.85M | ﹤0.01% |
+87,258
| New | +$1.85M |
|
1650
Tonix Pharmaceuticals
TNXP
$251M
| – | – |
0
| – | -$6.99M |
|